Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Freedman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Canadian Family Physician Medecin De Famille Canadien|January 22, 2022
Giovanna Sirianni, Betty Onyura, Sarah Kawaguchi, et al.
Drug Safety|March 2, 2021
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USAJames Weaver, Azza Shoaibi, Huy Q Truong, et al.
Current Medical Research and Opinion|April 28, 2020
Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database studyZhong Yuan, Frank DeFalco, Lu Wang, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Canadian Family Physician Medecin De Famille Canadien|January 22, 2022
Giovanna Sirianni, Betty Onyura, Sarah Kawaguchi, et al.
Drug Safety|March 2, 2021
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USAJames Weaver, Azza Shoaibi, Huy Q Truong, et al.
Current Medical Research and Opinion|April 28, 2020
Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database studyZhong Yuan, Frank DeFalco, Lu Wang, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
Pageof 2